Flyer; Alec Nathanson

Patent Applications and Registrations

Patent applications and USPTO patent grants for Flyer; Alec Nathanson.The latest application filed is for "1,2,4-oxadiazole derivatives as liver x receptor agonists".

Company Profile

4.10.14

Flyer; Alec Nathanson - Boston MA
FLYER; Alec Nathanson - Cambridge MA
FLYER; Alec Nathanson - Watertown MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,2,4-oxadiazole derivatives as liver X receptor agonists Grant 11,427,586 - Boss , et al. August 30, 2	2022-08-30
1,2,4-oxadiazole Derivatives As Liver X Receptor Agonists App 20220064164 - BOSS; Kelly D. ; et al.	2022-03-03
Cyclic Peptides As Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Inhibitors For The Treatment Of Metabolic Disorders App 20220024981 - FLYER; Alec Nathanson ; et al.	2022-01-27
Cyclic Tetramer Compounds As Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Inhibitors For The Treatment Of Metabolic Disorders App 20210252103 - BRINER; Karin ; et al.	2021-08-19
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders Grant 11,026,993 - Briner , et al. June 8, 2	2021-06-08
Cyclic Tetramer Compounds As Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) Inhibitors For The Treatment Of Metabolic Dis App 20200164024 - BRINER; Karin ; et al.	2020-05-28
Dissociable Nanoparticles With Inter Alia Transition-metal Complex Catalysts App 20190091673 - STERN; Eric ; et al.	2019-03-28
Cortistatin analogues and syntheses thereof Grant 10,202,400 - Flyer , et al. Feb	2019-02-12
Assay methods involving dissociable nanoparticles Grant 10,048,269 - Stern , et al. August 14, 2	2018-08-14
Cortistatin Analogues And Syntheses Thereof App 20170320886 - Flyer; Alec Nathanson ; et al.	2017-11-09
Cortistatin analogues and syntheses thereof Grant 9,714,255 - Flyer , et al. July 25, 2	2017-07-25
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators Grant 9,505,755 - Adams , et al. November 29, 2	2016-11-29
Assay Methods Involving Dissociable Nanoparticles App 20160047816 - Stern; Eric ; et al.	2016-02-18
Cortistatin Analogues And Syntheses Thereof App 20150376201 - Flyer; Alec Nathanson ; et al.	2015-12-31
Cortistatin analogues and synthesis thereof Grant 9,127,019 - Flyer , et al. September 8, 2	2015-09-08
Cortistatin Analogues And Syntheses Therof App 20150111921 - Flyer; Alec Nathanson ; et al.	2015-04-23
Tetrahydropyrido-pyridine And Tetrahydropyrido-pyrimidine Compounds And Use Thereof As C5a Receptor Modulators App 20140349995 - ADAMS; Christopher Michael ; et al.	2014-11-27
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators Grant 8,846,656 - Adams , et al. September 30, 2	2014-09-30
Tetrahydropyrido-pyridine And Tetrahydropyrido-pyrimidine Compounds And Use Thereof As C5a Receptor Modulators App 20130184253 - ADAMS; Christopher Michael ; et al.	2013-07-18
Cortistatin Analogues And Syntheses Thereof App 20110190323 - Flyer; Alec Nathanson ; et al.	2011-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.